Nothing Special   »   [go: up one dir, main page]

EP2475592B1 - Security label for securing medications retained in an individual packaging - Google Patents

Security label for securing medications retained in an individual packaging Download PDF

Info

Publication number
EP2475592B1
EP2475592B1 EP10768676.8A EP10768676A EP2475592B1 EP 2475592 B1 EP2475592 B1 EP 2475592B1 EP 10768676 A EP10768676 A EP 10768676A EP 2475592 B1 EP2475592 B1 EP 2475592B1
Authority
EP
European Patent Office
Prior art keywords
opening
label according
cuts
contour
safety label
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Not-in-force
Application number
EP10768676.8A
Other languages
German (de)
French (fr)
Other versions
EP2475592A1 (en
Inventor
Frank Ludwig
Reinhard Kuge
Marco Dieling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Faubel&Co Nachfolger GmbH
Original Assignee
Faubel&Co Nachfolger GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faubel&Co Nachfolger GmbH filed Critical Faubel&Co Nachfolger GmbH
Publication of EP2475592A1 publication Critical patent/EP2475592A1/en
Application granted granted Critical
Publication of EP2475592B1 publication Critical patent/EP2475592B1/en
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G09EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09FDISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
    • G09F3/00Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
    • G09F3/02Forms or constructions
    • G09F3/03Forms or constructions of security seals
    • G09F3/0305Forms or constructions of security seals characterised by the type of seal used
    • G09F3/0341Forms or constructions of security seals characterised by the type of seal used having label sealing means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035Blister-type containers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/36Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
    • B65D75/367Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed and forming several compartments
    • GPHYSICS
    • G09EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09FDISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
    • G09F3/00Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
    • G09F3/02Forms or constructions
    • G09F3/0291Labels or tickets undergoing a change under particular conditions, e.g. heat, radiation, passage of time
    • G09F3/0292Labels or tickets undergoing a change under particular conditions, e.g. heat, radiation, passage of time tamper indicating labels
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2215/00Child-proof means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2575/00Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
    • B65D2575/28Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by association or interconnecting two or more sheets or blanks
    • B65D2575/30Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D2575/32Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D2575/3209Details
    • B65D2575/3218Details with special means for gaining access to the contents
    • B65D2575/3227Cuts or weakening lines
    • B65D2575/3236Cuts or weakening lines for initiating or facilitating subsequent peeling off of the non-rigid sheet
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2575/00Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
    • B65D2575/28Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by association or interconnecting two or more sheets or blanks
    • B65D2575/30Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D2575/36One sheet or blank being recessed and the other formed or relatively stiff flat sheet material, e.g. blister packages
    • B65D2575/361Details
    • B65D2575/362Details with special means for gaining access to the contents
    • B65D2575/367Details with special means for gaining access to the contents through a preformed opening in the flat sheet, e.g. the opening being defined by weakened lines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/15Sheet, web, or layer weakened to permit separation through thickness

Definitions

  • the present invention relates to a security label for securing medicaments held in a single package according to the preamble of claim 1.
  • a blister pack consists of a number of troughs, in each of which a drug is packaged by means of a cover foil, usually made of aluminum. This cover film is easily pierced, with the result that the drug falls out or can be removed. As a result, there is a risk that the aluminum foil covering the medication accidentally tears open and the drug is soiled, lost or gets into unauthorized hands, for example, of young children.
  • a label for attachment to a blister pack has been proposed, which consists of a glued on the blister pack base sheet and adhered to the base sheet cover sheet.
  • This cover sheet is permanently adhered to the base sheet only in the area of its collar, while the largest part of the cover sheet due to a lacquer layer on the top of the base sheet removes and reseals glued to the base sheet.
  • longitudinal or cross slots are provided in the region of the center of the drugs, through which the individual drug can be pushed for the purpose of removal.
  • DE 10 2007 017 856 A1 is one in an area around the drug Perforation provided by which the single drug is pushed for the purpose of removal.
  • the present invention the object of the invention to provide a security label of the type mentioned, which provides sufficient resistance when removing the drug to provide protection against unauthorized opening by children or accidental opening.
  • a trained according to this technical teaching safety label has the advantage that the use of the opening cuts exclusively in a portion of the drug or drug drug leads to the fact that in the remaining portion remaining a closed protective layer that can not be broken. In practice, this means that the user must recognize that the medicament must be pushed into the apertured section and not in the remaining, closed residual section. This requires a mental maturity about which toddlers usually do not have. Without these considerations, only a small part of the drug trough is available for taking out the drug, while the remaining part prevents the removal, so that here a very high child safety is achieved.
  • the accidental opening is difficult because in this case the place with the opening cuts must be taken once.
  • the patient it is possible for the patient to recognize that the medicament is to be squeezed out at the place where the opening cuts are placed, so that the patient can remove the medicament without effort.
  • the opening portions are arranged equidistant from each other. This has the advantage that the corresponding opening sections are equally distributed in the respective section, so that viewed over the entire section, the same force is used to remove the medicament.
  • the opening cuts are radially aligned with respect to their virtual centerline. This ensures that the opening cuts remain in their section, for example in a quarter-circle segment, and that the resistance for removing the medicament is reduced towards the center, so that a once-pierced medicament can be removed in a simple manner.
  • the opening cuts are arranged in a quarter of the contour, for example in a quarter-circle segment, wherein the vertical Sections of the opening cuts or the centers of the opening cuts are arranged on the edge of the quarter of the contour. This ensures that all opening sections are in this section and that only a quarter of the total area is provided with opening cuts, while three quarters of the total area are firmly closed.
  • the opening cuts T-shaped and arranged with its first horizontal portion on the contour, preferably applied tangentially to the contour, while the second, vertical portion of the T-shaped opening section is aligned radially towards the center of the drug trough.
  • Another advantage is that by the formation of the opening section as T a relatively small opening is available, so that while an aid in squeezing out the drug, but that the basis otherwise consists of a continuous sheet, which upon pressing out of the drug be torn got to. The resulting resistance complicates the accidental pressing out of the drug or unauthorized opening of the blister by children.
  • the T-shaped opening cuts are arranged in a corner of a medicament trough of a single packaging, in particular if the medicament trough is not circular.
  • the ratio of the vertical section to the horizontal section should be between 0.3 and 2 times in order to provide sufficient resistance and, on the other hand, to allow even the weaker persons to remove the medication ,
  • an at least predominantly removable cover sheet is attached to the base.
  • Information on the medicine can be printed on this cover page. If you design this cover sheet again closed, so hereby a very neat and tidy impression of the entire individual packaging can be achieved, so that the individual packaging according to the invention even after repeated use still gives a sympathetic impression.
  • a first embodiment of a security label according to the invention which comprises a base 10, on the underside of adhesive 11 is mounted so that this security label can be glued to a single package 12, for example on a blister.
  • the individual packaging 12 comprises a medicament receptacle 13 formed from a dimensionally stable plastic with a number of medicament troughs 14 and an aluminum foil 15 adhered thereto, by means of which the individual medicaments 16 can be packaged in a sterile manner.
  • T-shaped opening cuts 17 are provided on a virtual circular path, not shown here, in this embodiment, four T-shaped opening cuts 17 are provided for each drug trough 14.
  • T-shaped opening cuts 17 are arranged with their horizontal portion 18 tangent to the virtual circle segment, while the vertical portions 19 of the T-shaped opening section 17 are aligned radially towards the center of the drug trough.
  • the three T-shaped opening cuts 17 provided here are arranged equidistant on the virtual circular path in such a way that the vertical sections 19 of the two outer of the opening sections 17 are arranged at a right angle to each other.
  • virtual circle segment is arranged concentrically to the edge of the medicament trough 14 shown here by dashed lines, wherein the distance between the virtual circle segment and the edge of the drug trough 14 is selected so that the drug 16 against pressing in the region of the virtual circle segment against the aluminum foil 15 and thus also against the base 10 presses.
  • T-shaped opening cut In another embodiment, not shown here, only a single T-shaped opening cut is provided for each drug. In yet another embodiment, not shown here, two, four or five T-shaped opening cuts per drug can be provided. This depends, in particular, on the resistance desired by the manufacturer, since the number of T-shaped opening cuts reduces the resistance when the medicament is pressed out.
  • the individual packaging mentioned here can be, for example, a blister or a wallet, but also any other packaging of medicaments in which the medicaments are accommodated individually in a specific cavity.
  • the vertical portions 19 are formed as long as the horizontal portions 18, wherein the portions 18, 19 are formed so small that adjacent opening cuts 17 have a significant distance from each other. This distance should be at least half the length of a horizontal section 18. It also follows that, although the vertical portion 19 is aligned in the direction of the center of the drug trough 14, but remains clearly spaced therefrom.
  • the aluminum foil 15 and the base 10 When pushing out the drug 16 from the individual packaging 12, the aluminum foil 15 and the base 10 must be pierced. If one tries to penetrate the drug in a region in which no T-shaped opening cuts 17 are provided, this will not succeed a normally strong patient. However, if the medicament 16 is pushed through in the area of the T-shaped opening cuts 17, the resistance at this point is reduced and a normally strong patient succeeds in piercing the aluminum foil 15 and the areas of the base 10 remaining outside the opening cuts Take drug 16. In this way, a certain parental control is achieved and accidental pressing of the drugs 16 is almost impossible.
  • FIG. 3 and FIG. 4 illustrated second embodiment of a security label according to the invention is identical with respect to the base 20 and the individual package 22 in the Fig. 1 and Fig. 2 shown first embodiment, however, a cover sheet 23 is additionally provided in this second embodiment, which is glued flush on the base 20.
  • a silicone layer 24 is applied, so that the cover sheet 23 can be opened several times and then reliably closed again.
  • Fig. 5 illustrated third embodiment differs from that in the Fig. 1 and Fig. 2 shown first embodiment only in that here the drug trough 34 of the individual packaging 32 is not circular, but is approximately square. Accordingly, the opening cuts 37 arranged in the base 30 are arranged on a virtual circle segment in a corner of the drug tray 34. The previously said when pushing out the drug applies here analogously.
  • FIGS. 6 to 15 Further embodiments of the security label are shown, which differ from the example in the Fig. 1 to Fig. 2a illustrated differ only by a differently designed opening section.
  • the opening cuts 47 are formed as upright "t".
  • the opening cuts 57 are formed as inverted "t".
  • the opening cuts 67 are formed as "H".
  • the opening cuts 77 are formed as "H with tapered vertical webs".
  • the opening cuts 87 are formed as upstanding "Y".
  • the opening cuts 97 are formed as inverted "Y".
  • the opening cuts 107 are formed as a "star".
  • the opening cuts 117 are formed as "X".
  • the opening cuts 127 are formed as "mirrored F".
  • the opening cuts 137 are formed as "I".
  • the opening cuts are formed as "L", wherein the lower ridge of the "L” is arranged in the clockwise direction.

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Computer Security & Cryptography (AREA)
  • Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Composite Materials (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)

Description

STAND DER TECHNIKSTATE OF THE ART

Die vorliegende Erfindung betrifft ein Sicherheitsetikett zum Sichern von in einer Einzelverpackung gehaltenen Medikamenten gemäß dem Oberbegriff des Anspruches 1.The present invention relates to a security label for securing medicaments held in a single package according to the preamble of claim 1.

Eine Blisterpackung besteht aus einer Anzahl von Trögen, in denen je ein Medikament mittels einer Abdeckfolie, meist aus Aluminium, verpackt ist. Diese Abdeckfolie lässt sich leicht Durchstoßen mit der Folge, dass das Medikament herausfällt, beziehungsweise entnommen werden kann. Hierdurch besteht die Gefahr, dass die die Medikamente abdeckende Alufolie auch versehentlich aufreißt und das Medikament beschmutzt wird, verloren geht oder in unbefugte Hände, zum Beispiel von kleinen Kindern, gelangt. Zur Sicherung einer solchen Blisterverpackung ist in der DE 10 2007 017 856 A1 ein Etikett zur Anbringung an einer Blisterpackung vorgeschlagen worden, welches aus einem an der Blisterpackung anklebbaren Basisblatt und einem an dem Basisblatt angeklebten Deckblatt besteht. Dieses Deckblatt ist nur im Bereich seines Bundes dauerhaft am Basisblatt angeklebt, während der größte Teil des Deckblattes aufgrund einer Lackschicht auf der Oberseite des Basisblattes ablösbar und wieder verschließbar am Basisblatt klebt. Im Basisblatt sind im Bereich des Mittelpunktes der Medikamente Längs-oder Kreuzschlitze vorgesehen, durch die das einzelne Medikament zwecks Entnahme hindurchgedrückt werden kann. In einer anderen Ausführungsform gemäß DE 10 2007 017 856 A1 ist in einem Bereich um das Medikament herum eine Perforation vorgesehen, durch die das einzelne Medikament zwecks Entnahme hindurchgedrückt wird.A blister pack consists of a number of troughs, in each of which a drug is packaged by means of a cover foil, usually made of aluminum. This cover film is easily pierced, with the result that the drug falls out or can be removed. As a result, there is a risk that the aluminum foil covering the medication accidentally tears open and the drug is soiled, lost or gets into unauthorized hands, for example, of young children. To secure such a blister pack is in the DE 10 2007 017 856 A1 a label for attachment to a blister pack has been proposed, which consists of a glued on the blister pack base sheet and adhered to the base sheet cover sheet. This cover sheet is permanently adhered to the base sheet only in the area of its collar, while the largest part of the cover sheet due to a lacquer layer on the top of the base sheet removes and reseals glued to the base sheet. In the base sheet longitudinal or cross slots are provided in the region of the center of the drugs, through which the individual drug can be pushed for the purpose of removal. In another embodiment according to DE 10 2007 017 856 A1 is one in an area around the drug Perforation provided by which the single drug is pushed for the purpose of removal.

Es hat sich herausgestellt, dass unter anderem auf Grund der großen Längs-bzw. Kreuzschlitze oder der Perforation der Widerstand beim Herausdrücken des Medikamentes noch verhältnismäßig gering ist, so dass die oben genannte Aufgabe nur bedingt gelöst wurde.It has been found that, inter alia, due to the large longitudinal or. Phillips or the perforation of the resistance when pushing out the drug is still relatively low, so that the above task was only partially solved.

Davon ausgehend liegt der vorliegenden Erfindung die Aufgabe zu Grunde, ein Sicherheitsetikett der eingangs genannten Art zu schaffen, welches einen ausreichenden Widerstand beim Herausnehmen des Medikamentes bietet, um einen Schutz gegen unbefugtes Öffnen durch Kinder oder ein versehentliches Öffnen zu bieten.On this basis, the present invention, the object of the invention to provide a security label of the type mentioned, which provides sufficient resistance when removing the drug to provide protection against unauthorized opening by children or accidental opening.

Als technische Lösung dieser Aufgabe wird erfindungsgemäß ein Sicherheitsetikett der eingangs genannten Art mit den Merkmalen des Anspruches 1 vorgeschlagen. Vorteilhafte Weiterbildungen dieses Sicherheitsetikettes sind den Unteransprüchen zu entnehmen.As a technical solution to this problem, a security label of the type mentioned is proposed according to the invention with the features of claim 1. Advantageous developments of this security label are given in the dependent claims.

Ein nach dieser technischen Lehre ausgebildetes Sicherheitsetikett hat den Vorteil, dass der Einsatz der Öffnungsschnitte ausschließlich in einem Teilabschnitt des Medikamentes oder Medikamententroges dazu führt, dass in dem verbleibenden Restabschnitt eine geschlossene Schutzschicht besteht, die nicht durchbrochen werden kann. In der Praxis bedeutet dies, dass der Benutzer erkennen muss, dass das Medikament in den mit den Öffnungen versehenen Teilabschnitt hindurchgedrückt werden muss und nicht in dem verbleibenden, geschlossenen Restabschnitt. Hierzu bedarf es einer geistigen Reife, über welche Kleinkinder in der Regel noch nicht verfügen. Ohne diese Überlegungen steht nur ein kleiner Teil des Medikamententroges zur Herausnahme des Medikamentes zur Verfügung, während der restliche Teil die Herausnahme verhindert, so dass hier eine sehr hohe Kindersicherheit erreicht wird.A trained according to this technical teaching safety label has the advantage that the use of the opening cuts exclusively in a portion of the drug or drug drug leads to the fact that in the remaining portion remaining a closed protective layer that can not be broken. In practice, this means that the user must recognize that the medicament must be pushed into the apertured section and not in the remaining, closed residual section. This requires a mental maturity about which toddlers usually do not have. Without these considerations, only a small part of the drug trough is available for taking out the drug, while the remaining part prevents the removal, so that here a very high child safety is achieved.

Hierdurch wird auch das versehentliche Öffnen erschwert, da in diesem Falle die Stelle mit den Öffnungsschnitten erst einmal getroffen werden muss. Gleichzeitig ist es dem Patienten möglich zu erkennen, dass das Medikament an der Stelle herauszudrücken ist, an der die Öffnungsschnitte platziert sind, so dass der Patient das Medikament ohne Mühe entnehmen kann.As a result, the accidental opening is difficult because in this case the place with the opening cuts must be taken once. At the same time, it is possible for the patient to recognize that the medicament is to be squeezed out at the place where the opening cuts are placed, so that the patient can remove the medicament without effort.

Ob im konkreten Fall nun zwei, drei, vier oder fünf Öffnungsschnitte vorgesehen sind, hängt vom Einzelfall ab, denn durch die Anzahl der Öffnungsschnitte kann der Schwierigkeitsgrad und der Widerstand beim Herausdrücken des Medikamentes eingestellt werden.Whether in the specific case now two, three, four or five opening sections are provided, depends on the individual case, because the number of opening cuts the degree of difficulty and the resistance can be set when pushing out the drug.

In einer bevorzugten Ausführungsform sind die Öffnungsabschnitte äquidistant zueinander angeordnet. Dies hat den Vorteil, dass die entsprechenden Öffnungsabschnitte in dem jeweiligen Teilabschnitt gleich verteilt sind, so dass über den gesamten Teilabschnitt betrachtet, die gleiche Kraft aufzuwenden ist, um das Medikament zu entnehmen.In a preferred embodiment, the opening portions are arranged equidistant from each other. This has the advantage that the corresponding opening sections are equally distributed in the respective section, so that viewed over the entire section, the same force is used to remove the medicament.

In einer anderen, bevorzugten Ausführungsform sind die Öffnungsschnitte bezüglich ihrer virtuellen Mittellinie radial ausgerichtet. Hierdurch ist sichergestellt, dass die Öffnungsschnitte in ihrem Teilabschnitt verbleiben, beispielsweise in einem Viertelkreissegment, und dass sich der Widerstand zum Herausnehmen des Medikamentes zum Mittelpunkt hin reduziert, so dass ein einmal durchgestoßenes Medikament in einfacher Weise entnommen werden kann.In another preferred embodiment, the opening cuts are radially aligned with respect to their virtual centerline. This ensures that the opening cuts remain in their section, for example in a quarter-circle segment, and that the resistance for removing the medicament is reduced towards the center, so that a once-pierced medicament can be removed in a simple manner.

In einer weiteren, bevorzugten Ausführungsform sind die Öffnungsschnitte in einem Viertel der Kontur, beispielsweise in einem Viertelkreissegment angeordnet, wobei die vertikalen Abschnitte der Öffnungsschnitte bzw. die Mittelpunkte der Öffnungsschnitte auf dem Rand des Viertels der Kontur angeordnet sind. Hierdurch wird erreicht, dass in diesem Teilabschnitt sämtliche Öffnungsschnitte liegen und dass lediglich ein Viertel der Gesamtfläche mit Öffnungsschnitte versehen ist, während dreiviertel der Gesamtfläche fest verschlossen sind.In a further preferred embodiment, the opening cuts are arranged in a quarter of the contour, for example in a quarter-circle segment, wherein the vertical Sections of the opening cuts or the centers of the opening cuts are arranged on the edge of the quarter of the contour. This ensures that all opening sections are in this section and that only a quarter of the total area is provided with opening cuts, while three quarters of the total area are firmly closed.

In der Praxis hat es sich als vorteilhaft erwiesen, den Öffnungsschnitt T-förmig, t-förmig, H-förmig, F-förmig, X-förmig, Y-förmig oder sternförmig auszubilden. Bei all diesen Schnitten ist ein Durchstoßen des Sicherheitsetikettes mit einem gewissen Kraftaufwand möglich.In practice, it has proved to be advantageous to form the opening section T-shaped, T-shaped, H-shaped, F-shaped, X-shaped, Y-shaped or star-shaped. With all these cuts a penetration of the security label with a certain effort is possible.

In einer ganz bevorzugten Ausführungsform sind die Öffnungsschnitte T-förmig ausgebildet und mit ihrem ersten horizontalen Abschnitt auf der Kontur angeordnet, vorzugsweise tangential an der Kontur angelegt, während der zweite, vertikale Abschnitt des T-förmigen Öffnungsschnittes radial zur Mitte des Medikamententroges hin ausgerichtet ist. Dies hat den Vorteil, dass einerseits entlang der Kontur Schnitte angeordnet sind und dass andererseits in radialer Richtung Schnitte angeordnet sind. Hierdurch ist es in einfacher Weise möglich, das Medikament mit seinem Rand gegen das Sicherheitsetikett zu drücken, wobei der Rand nahe der Kontur anstößt und dort auf ein vergleichsweise geringen Widerstand stößt. Beim weiteren Hindurchdrücken des Medikamentes blättert sich dann das Sicherheitsetikett auf und das Medikament kann entnommen werden.In a very preferred embodiment, the opening cuts T-shaped and arranged with its first horizontal portion on the contour, preferably applied tangentially to the contour, while the second, vertical portion of the T-shaped opening section is aligned radially towards the center of the drug trough. This has the advantage that, on the one hand, cuts are arranged along the contour and, on the other hand, cuts are arranged in the radial direction. This makes it possible in a simple manner to press the drug with its edge against the security label, wherein the edge abuts near the contour and there encounters a relatively low resistance. Upon further pressing of the drug, the security label then flakes and the drug can be removed.

Ein weiterer Vorteil besteht darin, dass durch die Ausbildung des Öffnungsschnittes als T eine verhältnismäßig kleine Öffnung bereit steht, so dass hierdurch zwar eine Hilfe beim Herausdrücken des Medikamentes besteht, dass aber die Grundlage im Übrigen aus einem zusammenhängenden Blatt besteht, welches beim Herausdrücken des Medikamentes zerrissen werden muss. Der hierbei entstehende Widerstand erschwert das versehentliche Herausdrücken des Medikamentes oder das unbefugte Öffnen des Blisters durch Kinder.Another advantage is that by the formation of the opening section as T a relatively small opening is available, so that while an aid in squeezing out the drug, but that the basis otherwise consists of a continuous sheet, which upon pressing out of the drug be torn got to. The resulting resistance complicates the accidental pressing out of the drug or unauthorized opening of the blister by children.

In einer alternativen Ausführungsform sind die T-förmigen Öffnungsschnitte in einer Ecke eines Medikamententroges einer Einzelverpackung angeordnet, insbesondere dann, wenn der Medikamententrog nicht kreisrund ausgebildet ist. Die oben genannten Vorteile gelten hier analog.In an alternative embodiment, the T-shaped opening cuts are arranged in a corner of a medicament trough of a single packaging, in particular if the medicament trough is not circular. The above advantages apply analogously.

In der Praxis hat sich herausgestellt, dass das Verhältnis vom vertikalen Abschnitt zum horizontalen Abschnitt zwischen dem 0,3-fachen und dem 2-fachen liegen sollte, um einerseits genügend Widerstand zu bieten und um andererseits auch schwächeren Personen noch die Entnahme der Medikamente zu ermöglichen.In practice, it has been found that the ratio of the vertical section to the horizontal section should be between 0.3 and 2 times in order to provide sufficient resistance and, on the other hand, to allow even the weaker persons to remove the medication ,

In einer ganz besonders bevorzugten Ausführungsform ist an der Grundlage ein zumindest überwiegend ablösbares Deckblatt angebracht. An diesem Deckblatt können Informationen zum Medikament aufgedruckt werden. Gestaltet man dieses Deckblatt wieder verschließbar, so kann hiermit auch ein sehr ordentlicher und aufgeräumter Eindruck der gesamten Einzelverpackung erreicht werden, so dass die erfindungsgemäße Einzelverpackung auch nach mehrmaligem Gebrauch noch einen sympathischen Eindruck vermittelt.In a very particularly preferred embodiment, an at least predominantly removable cover sheet is attached to the base. Information on the medicine can be printed on this cover page. If you design this cover sheet again closed, so hereby a very neat and tidy impression of the entire individual packaging can be achieved, so that the individual packaging according to the invention even after repeated use still gives a sympathetic impression.

Weitere Vorteile des erfindungsgemäßen Sicherheitsetikettes ergeben sich aus der beigefügten Zeichnung und den nachstehend beschriebenen Ausführungsformen. Ebenso können die vorstehend genannten und die noch weiter ausgeführten Merkmale erfindungsgemäß jeweils einzeln oder in beliebigen Kombinationen miteinander verwendet werden. Die erwähnten Ausführungsformen sind nicht als abschließende Aufzählung zu verstehen, sondern haben vielmehr beispielhaften Charakter. Es zeigen:

  • Fig. 1 eine geschnitten dargestellte Explosionsdarstellung einer ersten Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes mit einer Blisterverpackung, geschnitten entlang Linie I-I in Fig. 2;
  • Fig. 2 eine Draufsicht auf das Sicherheitsetikett gemäß Fig. 1;
  • Fig. 2a eine Detailvergrößerung des Sicherheitsetikettes gemäß Linie IIa in Fig. 2;
  • Fig. 3 eine geschnitten dargestellte Explosionsdarstellung einer zweiten Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes mit einer Blisterverpackung, geschnitten entlang Linie III-III in Fig. 4;
  • Fig. 4 eine Draufsicht auf das Sicherheitsetikett gemäß Fig. 3 entsprechend Linie IV-IV in Fig. 3;
  • Fig. 5 eine Draufsicht auf eine dritte Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes;
  • Fig. 6 eine Draufsicht auf eine vierte Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes;
  • Fig. 7 eine Draufsicht auf eine fünfte Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes;
  • Fig. 8 eine Draufsicht auf eine sechste Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes;
  • Fig. 9 eine Draufsicht auf eine siebte Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes;
  • Fig. 10 eine Draufsicht auf eine achte Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes;
  • Fig. 11 eine Draufsicht auf eine neunte Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes;
  • Fig. 12 eine Draufsicht auf eine zehnte Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes;
  • Fig. 13 eine Draufsicht auf eine elfte Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes;
  • Fig. 14 eine Draufsicht auf eine zwölfte Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes;
  • Fig. 15 eine Draufsicht auf eine dreizehnte Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes;
  • Fig. 16 eine Draufsicht auf eine vierzehnte Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes;
  • Fig. 17 eine Draufsicht auf eine fünfzehnte Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes.
Further advantages of the security label according to the invention will become apparent from the accompanying drawings and the embodiments described below. Likewise, according to the invention, the above-mentioned features and those which are still further developed can be used individually or in any desired combinations with one another. The mentioned embodiments are not to be understood as an exhaustive list, but rather have exemplary character. Show it:
  • Fig. 1 a cutaway exploded view of a first embodiment of a security label according to the invention with a blister pack, cut along line II in Fig. 2 ;
  • Fig. 2 a plan view of the security label according to Fig. 1 ;
  • Fig. 2a an enlarged detail of the security label according to line IIa in Fig. 2 ;
  • Fig. 3 an exploded sectional view of a second embodiment of a security label according to the invention with a blister pack, cut along line III-III in Fig. 4 ;
  • Fig. 4 a plan view of the security label according to Fig. 3 according to line IV-IV in Fig. 3 ;
  • Fig. 5 a plan view of a third embodiment of a security label according to the invention;
  • Fig. 6 a plan view of a fourth embodiment of a security label according to the invention;
  • Fig. 7 a plan view of a fifth embodiment of a security label according to the invention;
  • Fig. 8 a plan view of a sixth embodiment of a security label according to the invention;
  • Fig. 9 a plan view of a seventh embodiment of a security label according to the invention;
  • Fig. 10 a plan view of an eighth embodiment of a security label according to the invention;
  • Fig. 11 a plan view of a ninth embodiment of a security label according to the invention;
  • Fig. 12 a plan view of a tenth embodiment of a security label according to the invention;
  • Fig. 13 a plan view of an eleventh embodiment of a security label according to the invention;
  • Fig. 14 a plan view of a twelfth embodiment of a security label according to the invention;
  • Fig. 15 a plan view of a thirteenth embodiment of a security label according to the invention;
  • Fig. 16 a plan view of a fourteenth embodiment of a security label according to the invention;
  • Fig. 17 a plan view of a fifteenth embodiment of a security label according to the invention.

In den Fig. 1, Fig. 2 und Fig. 2a ist eine erste Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes dargestellt, welches eine Grundlage 10 umfasst, an deren Unterseite Klebstoff 11 angebracht ist, damit dieses Sicherheitsetikett auf eine Einzelverpackung 12 , zum Beispiel auf einem Blister, aufgeklebt werden kann. Die Einzelverpackung 12 umfasst eine aus einem formstabilen Kunststoff gebildete Medikamentenaufnahme 13 mit einer Anzahl von Medikamententrögen 14 und einer darauf aufgeklebten Alufolie 15 , mittels der die einzelnen Medikamente 16 steril verpackt werden können. In der Grundlage 10 sind auf einer hier nicht näher dargestellten, virtuellen Kreisbahn T-förmige Öffnungsschnitte 17 vorgesehen, wobei in dieser Ausführungsform für jeden Medikamententrog 14 drei T-förmige Öffnungsschnitte 17 vorgesehen sind. Dabei sind T-förmigen Öffnungsschnitte 17 mit ihrem horizontalen Abschnitt 18 tangential an dem virtuellen Kreissegment angeordnet, während die vertikalen Abschnitte 19 des T-förmigen Öffnungsschnittes 17 radial zur Mitte des Medikamententroges hin ausgerichtet sind. Die drei hier vorgesehenen T-förmigen Öffnungsschnitte 17 sind dabei derart äquidistant auf der virtuellen Kreisbahn angeordnet, dass die vertikalen Abschnitte 19 der beiden äußeren der Öffnungsschnitte 17 quasi rechtwinklig zueinander angeordnet sind.In the Fig. 1, Fig. 2 and Fig. 2a a first embodiment of a security label according to the invention is shown, which comprises a base 10, on the underside of adhesive 11 is mounted so that this security label can be glued to a single package 12, for example on a blister. The individual packaging 12 comprises a medicament receptacle 13 formed from a dimensionally stable plastic with a number of medicament troughs 14 and an aluminum foil 15 adhered thereto, by means of which the individual medicaments 16 can be packaged in a sterile manner. In the base 10 T-shaped opening cuts 17 are provided on a virtual circular path, not shown here, in this embodiment, four T-shaped opening cuts 17 are provided for each drug trough 14. In this case, T-shaped opening cuts 17 are arranged with their horizontal portion 18 tangent to the virtual circle segment, while the vertical portions 19 of the T-shaped opening section 17 are aligned radially towards the center of the drug trough. The three T-shaped opening cuts 17 provided here are arranged equidistant on the virtual circular path in such a way that the vertical sections 19 of the two outer of the opening sections 17 are arranged at a right angle to each other.

Das in der Zeichnung nicht eingezeichnete, virtuelle Kreissegment ist konzentrisch zum hier gestrichelt dargestellten Rand des Medikamententroges 14 angeordnet, wobei der Abstand zwischen dem virtuellen Kreissegment und dem Rand des Medikamententroges 14 so gewählt ist, dass das Medikament 16 beim Herausdrücken im Bereich des virtuellen Kreissegmentes gegen die Alufolie 15 und damit auch gegen die Grundlage 10 drückt.The not shown in the drawing, virtual circle segment is arranged concentrically to the edge of the medicament trough 14 shown here by dashed lines, wherein the distance between the virtual circle segment and the edge of the drug trough 14 is selected so that the drug 16 against pressing in the region of the virtual circle segment against the aluminum foil 15 and thus also against the base 10 presses.

In einer anderen, hier nicht dargestellten Ausführungsform ist für jedes Medikament nur ein einziger T-förmiger Öffnungsschnitt vorgesehen. In noch einer anderen, hier nicht dargestellten Ausführungsform können auch zwei, vier oder fünf T-förmige Öffnungsschnitte je Medikament vorgesehen werden. Dies richtet sich insbesondere nach dem vom Hersteller gewünschten Widerstand, da mit der Anzahl der T-förmigen Öffnungsschnitte der Widerstand beim Herausdrücken des Medikamentes geringer wird.In another embodiment, not shown here, only a single T-shaped opening cut is provided for each drug. In yet another embodiment, not shown here, two, four or five T-shaped opening cuts per drug can be provided. This depends, in particular, on the resistance desired by the manufacturer, since the number of T-shaped opening cuts reduces the resistance when the medicament is pressed out.

Die hier erwähnte Einzelverpackung kann beispielsweise ein Blister oder ein Wallet sein, aber auch jede andere Verpackung von Medikamenten, bei der die Medikamente einzeln in einem bestimmten Hohlraum untergebracht sind.The individual packaging mentioned here can be, for example, a blister or a wallet, but also any other packaging of medicaments in which the medicaments are accommodated individually in a specific cavity.

In der hier dargestellten, ersten Ausführungsform sind die vertikalen Abschnitte 19 genauso lang ausgebildet, wie die horizontalen Abschnitte 18 , wobei die Abschnitte 18 , 19 so klein ausgebildet sind, dass benachbarte Öffnungsschnitte 17 einen deutlichen Abstand voneinander haben. Dieser Abstand sollte mindestens die Hälfte der Länge eines horizontalen Abschnittes 18 betragen. Daraus ergibt sich auch, dass der vertikale Abschnitt 19 zwar in Richtung des Mittelpunktes des Medikamententroges 14 ausgerichtet ist, jedoch von diesem deutlich beabstandet bleibt.In the first embodiment shown here, the vertical portions 19 are formed as long as the horizontal portions 18, wherein the portions 18, 19 are formed so small that adjacent opening cuts 17 have a significant distance from each other. This distance should be at least half the length of a horizontal section 18. It also follows that, although the vertical portion 19 is aligned in the direction of the center of the drug trough 14, but remains clearly spaced therefrom.

Beim Herausdrücken des Medikamentes 16 aus der Einzelverpackung 12 muss die Alufolie 15 und die Grundlage 10 durchstoßen werden. Versucht man das Medikament in einem Bereich durchzustoßen, in dem keine T-förmigen Öffnungsschnitte 17 vorgesehen sind, so wird dies einem normal starken Patienten nicht gelingen. Wird das Medikament 16 allerdings im Bereich der T-förmigen Öffnungsschnitte 17 durchgedrückt, so ist der Widerstand an dieser Stelle reduziert, und es gelingt einem normal starken Patienten, die Alufolie 15 und die außerhalb der Öffnungsschnitte verbleibenden Bereiche der Grundlage 10 zu durchstoßen, um das Medikament 16 zu entnehmen. Auf diese Weise ist eine gewisse Kindersicherung erreicht und auch ein versehentliches Durchdrücken der Medikamente 16 wird fast unmöglich.When pushing out the drug 16 from the individual packaging 12, the aluminum foil 15 and the base 10 must be pierced. If one tries to penetrate the drug in a region in which no T-shaped opening cuts 17 are provided, this will not succeed a normally strong patient. However, if the medicament 16 is pushed through in the area of the T-shaped opening cuts 17, the resistance at this point is reduced and a normally strong patient succeeds in piercing the aluminum foil 15 and the areas of the base 10 remaining outside the opening cuts Take drug 16. In this way, a certain parental control is achieved and accidental pressing of the drugs 16 is almost impossible.

Die in Fig. 3 und Fig. 4 dargestellte zweite Ausführungsform eines erfindungsgemäßen Sicherheitsetikettes ist betreffend die Grundlage 20 und die Einzelverpackung 22 identisch mit der in den Fig. 1 und Fig. 2 gezeigten ersten Ausführungsform, jedoch ist in dieser zweiten Ausführungsform zusätzlich ein Deckblatt 23 vorgesehen, welches bündig auf der Grundlage 20 aufgeklebt ist. Zusätzlich ist auf der Grundlage 20 bis auf einen Bund 25 eine Silikonschicht 24 aufgebracht, so dass das Deckblatt 23 mehrfach geöffnet und anschließend wieder zuverlässig verschlossen werden kann.In the FIG. 3 and FIG. 4 illustrated second embodiment of a security label according to the invention is identical with respect to the base 20 and the individual package 22 in the Fig. 1 and Fig. 2 shown first embodiment, however, a cover sheet 23 is additionally provided in this second embodiment, which is glued flush on the base 20. In addition, on the basis of 20 except for a collar 25, a silicone layer 24 is applied, so that the cover sheet 23 can be opened several times and then reliably closed again.

Die in Fig. 5 dargestellte dritte Ausführungform unterscheidet von der in den Fig. 1 und Fig. 2 dargestellten ersten Ausführungsform lediglich dadurch, dass hier der Medikamententrog 34 der Einzelverpackung 32 nicht kreisrund, sondern annähernd viereckig ausgebildet ist. Dementsprechend sind die in der Grundlage 30 angeordneten Öffnungsschnitte 37 auf einem virtuellen Kreissegment in einer Ecke des Medikamententroges 34 angeordnet. Das zuvor Gesagte beim Herausdrücken des Medikamentes gilt hier analog.In the Fig. 5 illustrated third embodiment differs from that in the Fig. 1 and Fig. 2 shown first embodiment only in that here the drug trough 34 of the individual packaging 32 is not circular, but is approximately square. Accordingly, the opening cuts 37 arranged in the base 30 are arranged on a virtual circle segment in a corner of the drug tray 34. The previously said when pushing out the drug applies here analogously.

In den Fig. 6 bis Fig. 15 sind weitere Ausführungsformen des Sicherheitsetikettes dargestellt, die sich von der beispielsweise in den Fig. 1 bis Fig. 2a dargestellten ersten Ausführungsform lediglich durch einen anders gestalteten Öffnungsschnitt unterscheiden.In the FIGS. 6 to 15 Further embodiments of the security label are shown, which differ from the example in the Fig. 1 to Fig. 2a illustrated differ only by a differently designed opening section.

In der in Fig. 6 dargestellten vierten Ausführungsform sind die Öffnungsschnitte 47 als aufrechtstehendes "t" ausgebildet.In the in Fig. 6 illustrated fourth embodiment, the opening cuts 47 are formed as upright "t".

In der in Fig. 7 dargestellten fünften Ausführungsform sind die Öffnungsschnitte 57 als kopfstehendes "t" ausgebildet.In the in Fig. 7 illustrated fifth embodiment, the opening cuts 57 are formed as inverted "t".

In der in Fig. 8 dargestellten sechsten Ausführungsform sind die Öffnungsschnitte 67 als "H" ausgebildet.In the in Fig. 8 illustrated sixth embodiment, the opening cuts 67 are formed as "H".

In der in Fig. 9 dargestellten siebten Ausführungsform sind die Öffnungsschnitte 77 als "H mit konisch zulaufenden Vertikalstegen" ausgebildet.In the in Fig. 9 illustrated seventh embodiment, the opening cuts 77 are formed as "H with tapered vertical webs".

In der in Fig. 10 dargestellten achten Ausführungsform sind die Öffnungsschnitte 87 als aufrechtstehendes "Y" ausgebildet.In the in Fig. 10 illustrated eighth embodiment, the opening cuts 87 are formed as upstanding "Y".

In der in Fig. 11 dargestellten neunten Ausführungsform sind die Öffnungsschnitte 97 als kopfstehendes "Y" ausgebildet.In the in Fig. 11 9 illustrated ninth embodiment, the opening cuts 97 are formed as inverted "Y".

In der in Fig. 12 dargestellten zehnten Ausführungsform sind die Öffnungsschnitte 107 als "Stern" ausgebildet.In the in Fig. 12 illustrated tenth embodiment, the opening cuts 107 are formed as a "star".

In der in Fig. 13 dargestellten elften Ausführungsform sind die Öffnungsschnitte 117 als "X" ausgebildet.In the in Fig. 13 illustrated eleventh embodiment, the opening cuts 117 are formed as "X".

In der in Fig. 14 dargestellten zwölften Ausführungsform sind die Öffnungsschnitte 127 als "gespiegeltes F" ausgebildet.In the in Fig. 14 12 illustrated embodiment, the opening cuts 127 are formed as "mirrored F".

In der in Fig. 15 dargestellten dreizehnten Ausführungsform sind die Öffnungsschnitte 137 als "I" ausgebildet.In the in Fig. 15 illustrated thirteenth embodiment, the opening cuts 137 are formed as "I".

In der in Fig. 16 dargestellten vierzehnten Ausführungsform sind die Öffnungsschnitte als "L" wobei der untere Steg des "L" entgegen der Uhrzeigerrichtung angeordnet ist.In the in Fig. 16 fourteenth embodiment shown, the opening cuts as "L" with the lower ridge of the "L" is arranged in the counterclockwise direction.

In der Fig. 17 dargestellten fünfzehnten Ausführungsform sind die Öffnungsschnitte als "L" ausgebildet, wobei der untere Steg des "L" im Uhrzeigerrichtung angeordnet ist. Bezugszeichenliste: 10, 20, 30 Grundlage 11, 21 Klebstoff 12, 22, 32 Einzelverpackung 13 Medikamentenaufnahme 23 Deckblatt 14, 34 Medikamententrog 24 Silikonschicht 15 Alufolie 25 Bund 16 Medikament 17, 37 Öffnungsschnitte 47, 57, 67, 77, 87, 97, 107, 117, 127, 137, 147, 157 Öff-nungsschnitte 18 horizontaler Abschnitt 19 vertikaler Abschnitt In the Fig. 17 illustrated fifteenth embodiment, the opening cuts are formed as "L", wherein the lower ridge of the "L" is arranged in the clockwise direction. LIST OF REFERENCE NUMBERS 10, 20, 30 basis 11, 21 adhesive 12, 22, 32 individual packaging 13 drug absorption 23 cover sheet 14, 34 drugs trough 24 silicone layer 15 aluminum foil 25 Federation 16 drug 17, 37 opening cuts 47, 57, 67, 77, 87, 97, 107, 117, 127, 137, 147, 157 Öff-voltage sections 18 horizontal section 19 vertical section

Claims (9)

  1. Safety label for protecting medicaments contained in an individual packaging, having a base sublayer (10, 20, 30) which can be adhesively bonded onto the individual packaging (12, 22, 32), wherein at least one opening cut (17, 37, 47, 57, 67, 77, 87, 97, 107, 117, 127, 137, 147, 157) per medicament (16) is provided in the base sublayer (10, 20, 30) in the region of the medicaments (16) to be expected, wherein the opening cut (17, 37, 47, 57, 67, 77, 87, 97, 107, 117, 127, 137, 147, 157) has at least one first and one second partial cut, and wherein the first partial cut and the second partial cut meet or intersect, characterized in that two, three, four or five opening cuts (17, 37, 47, 57, 67, 77, 87, 97, 107, 117, 127, 137, 147, 157) are provided in the region of the medicament (16) to be expected, in that the opening cuts (17, 37, 47, 57, 67, 77, 87, 97, 107, 117, 127, 137, 147, 157) are arranged exclusively along a part portion of the contour of the medicament (16) or along a part portion of the contour of the medicament trough, wherein the part portion is approximately half to a sixth, preferably a quarter, of the contour.
  2. Safety label according to Claim 1, characterized in that the opening cuts (17, 37, 47, 57, 67, 77, 87, 97, 107, 117, 127, 137, 147, 157) are arranged equidistantly with respect to one another.
  3. Safety label according to one of the preceding claims, characterized in that the opening cuts (17, 37, 47, 57, 67, 77, 87, 97, 107, 117, 127, 137, 147, 157) are orientated radially with respect to their virtual center line.
  4. Safety label according to one of the preceding claims, characterized in that the opening cuts (17, 37, 47, 57, 67, 77, 87, 97, 107, 117, 127, 137, 147, 157) are arranged in a quarter of the contour such that the vertical portions of the opening cuts (17, 37, 47, 57, 67, 77, 87, 97, 107, 117, 127, 137, 147, 157) or the center points of the opening cuts (17, 37, 47, 57, 67, 77, 87, 97, 107, 117, 127, 137) are arranged on the edge of the quarter of the contour.
  5. Safety label according to one of the preceding claims, characterized in that the opening cut is configured in the shape of a T (17, 37), t (47, 57), H (67), F (127), X (117), Y (87, 97) or a star (107).
  6. Safety label according to Claim 5, characterized in that the T-shaped opening cuts (17, 37) are arranged with their first, horizontal portion (18) on the contour.
  7. Safety label according to Claim 6, characterized in that the first, horizontal portion (18) of the T-shaped opening cut (17) bears tangentially against the contour, while the second, vertical portion (19) of the T-shaped opening cut (17) is orientated radially in the direction of the center of the medicament trough (14, 34).
  8. Safety label according to one of Claims 5 to 7, characterized in that the vertical portion (19) of the T-shaped opening cut (17) is approximately 0.3 times to twice as long, preferably as long, as the horizontal portion (18) of the T-shaped opening cut (17).
  9. Safety label according to one of the preceding claims, characterized in that a cover sheet (22), which is at least mostly detachable, is attached to the base sublayer (20).
EP10768676.8A 2009-09-08 2010-08-31 Security label for securing medications retained in an individual packaging Not-in-force EP2475592B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200920012186 DE202009012186U1 (en) 2009-09-08 2009-09-08 Security label for securing medicines held in a single package
PCT/DE2010/001022 WO2011029421A1 (en) 2009-09-08 2010-08-31 Security label for securing medications retained in an individual packaging

Publications (2)

Publication Number Publication Date
EP2475592A1 EP2475592A1 (en) 2012-07-18
EP2475592B1 true EP2475592B1 (en) 2014-02-26

Family

ID=41413259

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10768676.8A Not-in-force EP2475592B1 (en) 2009-09-08 2010-08-31 Security label for securing medications retained in an individual packaging

Country Status (6)

Country Link
US (1) US8865283B2 (en)
EP (1) EP2475592B1 (en)
CN (1) CN102548866A (en)
DE (1) DE202009012186U1 (en)
DK (1) DK2475592T3 (en)
WO (1) WO2011029421A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202009012194U1 (en) 2009-09-08 2009-11-26 Faubel & Co. Nachfolger Gmbh Security label for securing medicines held in a single package
DE202012009135U1 (en) 2012-09-24 2012-12-07 Faubel & Co. Nachfolger Gmbh blister
TWI674995B (en) * 2019-03-04 2019-10-21 曹建華 Packaging container
CN112396949A (en) * 2019-08-13 2021-02-23 余丽 Activation method of environment-friendly low-temperature protection failure prompt label

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3759371A (en) * 1972-07-12 1973-09-18 R Marks Containers for small articles such as pills
BRPI0408565A (en) * 2003-03-20 2006-03-21 Wade E Williams-Hartman child resistant and elderly friendly blister card packaging
US6974032B2 (en) * 2003-07-30 2005-12-13 Intini Thomas D Bend and peel packaging having controllable delamination
US20070227932A1 (en) * 2003-12-10 2007-10-04 3Point Blue Limited Blister Packs
US7497331B2 (en) * 2005-05-04 2009-03-03 Duramed Pharmaceuticals, Inc. Child resistant package
DE202006007553U1 (en) * 2006-05-10 2006-07-13 Harro Höfliger Verpackungsmaschinen GmbH Childproof wallet for tablets has at least one tablet in individual blister cutout detachably fitted to remainder of blister
MX2009002954A (en) * 2006-09-26 2009-03-31 Cadbury Adams Usa Llc Rupturable blister package.
DE102007017856A1 (en) 2007-04-13 2008-10-16 Faubel & Co. Nachfolger Gmbh Label for mounting base sheet on blister pack, has back side provided with adhesive for gluing on blister pack, where cover sheet is arranged on front side of base sheet, which covers base sheet in preponderant manner

Also Published As

Publication number Publication date
US8865283B2 (en) 2014-10-21
US20120196072A1 (en) 2012-08-02
WO2011029421A1 (en) 2011-03-17
EP2475592A1 (en) 2012-07-18
CN102548866A (en) 2012-07-04
DK2475592T3 (en) 2014-05-12
DE202009012186U1 (en) 2009-12-10

Similar Documents

Publication Publication Date Title
DE60202458T2 (en) CHILDREN-PROOF PACKAGING FOR PHARMACEUTICAL PRODUCTS
DE60102699T2 (en) SINGLE DOSE BLISTER PACKING WITH KEYBOARD OPENING
DE69832280T2 (en) CARRIER FOR BLISTER PACKAGING
EP1838595B1 (en) Film container
DE2743574A1 (en) DISPENSER CONTAINER FOR SINGLE DISPENSING OF SMALL ITEMS
DE69506267T2 (en) BLISTER PACK WITH DRYING AGENT
EP2475593B1 (en) Security label for protecting medicaments contained in an individual packaging
WO2008119602A1 (en) Blister arrangement and cardboard blank therefor
EP2475592B1 (en) Security label for securing medications retained in an individual packaging
EP2475594B1 (en) Security label for protecting medicaments contained in an individual packaging
DE3317549A1 (en) Device for removing capsules, tablets or sugar-coated tablets from blister packs
EP0045449B1 (en) Childproof package for medicaments
EP1270440B1 (en) Child proof blister package
EP1108413B1 (en) Use of a blister package
DE102013107410B4 (en) Multi-layer label
DE2543069C3 (en) Child-safe blister pack
DE2930417A1 (en) Package for medicine - in standard box with transparent window for slider with cut=out for buster packing
DE29921100U1 (en) Blister pack
EP3924267B1 (en) Child-proof packaging
DE102009042858A1 (en) Arrangement for retaining pharmaceutical blister utilized for storing e.g. pill, has first layer adjusted relative to second and third layers, such that recess of first layer is arranged over recess of second layer or third layer
AT517864B1 (en) Overpack for blister packaging
DE202006021043U1 (en) Drug supply system
DE2321604A1 (en) CHILD RESISTANT PACKAGING
DE10355797A1 (en) Childproof packaging for tablets comprises a blister element having a lower side covered by several protective elements with recesses to allow an object to pass through
EP2108600A1 (en) Childproof blister packaging

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120410

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20130121

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20130920

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 653452

Country of ref document: AT

Kind code of ref document: T

Effective date: 20140315

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502010006192

Country of ref document: DE

Effective date: 20140403

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20140505

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140526

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140626

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140626

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502010006192

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20140820

Year of fee payment: 5

26N No opposition filed

Effective date: 20141127

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502010006192

Country of ref document: DE

Effective date: 20141127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140831

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 502010006192

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140527

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20100831

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150831

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20170823

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20170824

Year of fee payment: 8

Ref country code: FR

Payment date: 20170823

Year of fee payment: 8

Ref country code: CH

Payment date: 20170830

Year of fee payment: 8

Ref country code: IT

Payment date: 20170824

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20170821

Year of fee payment: 8

Ref country code: DK

Payment date: 20170824

Year of fee payment: 8

Ref country code: SE

Payment date: 20170830

Year of fee payment: 8

Ref country code: IE

Payment date: 20170822

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20140226

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20180831

Year of fee payment: 9

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

Effective date: 20180831

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: MM

Effective date: 20180901

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 653452

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180831

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20180831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180831

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180831

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180831

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180831

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180831

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 502010006192

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200303